765 Randomized, Placebo-controlled, Double-blind, Dose Response (rpcdbdr) Trial of Cts-1027, an Inhibitor of Matrix Metalloproteases (mmps) in Patients With Hcv Who Had Failed Prior Therapies
Year: 2010
Type: article
Source: Journal of Hepatology
Authors: P.J. Pockros, S.C. Gordon, A. McCullough, M. Charlton, N. Bzowej, J. Vierling, M. Bansal, B. Yoffe, G. Everson, M. Huyghe, A. Fox, S. Mento, O. Bohm, B. Plouffe, R. Cross, M. Shiffman
Institutions: Scripps Clinic, Harvard University, Henry Ford Hospital, Massachusetts General Hospital, Cleveland Clinic, University of Washington, Mayo Clinic, California Pacific Medical Center, Baylor St. Luke's Medical Center, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, Baylor College of Medicine, University of Colorado Denver, Conatus Pharmaceuticals (United States), FGK Clinical Research, iQur (United Kingdom), Virginia Commonwealth University
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1988489986